Doxofylline belongs to the methylxanthine class, offering a distinct profile compared to its relatives, theophylline and caffeine. Chemically, it carries the molecular formula C11H14N4O4, lining up key atoms in a unique structure that helps set apart its pharmacological action. A close look shows the presence of a dioxolane ring fused to a xanthine base, which impacts solubility, reactivity, and how the compound interacts with biological systems. Doxofylline typically appears as a solid at room temperature and can show up in several physical forms — from fine white powder to crystalline flakes, depending on the refinement process used during synthesis.
The molecular weight clocks in around 266.26 g/mol, providing a stable balance between structure and activity. Doxofylline is generally classed as a solid and rarely encountered as a pearl, bead, or liquid. Often, it arrives in raw material shipments as white, odorless powder. That powder flows easily and resists clumping, making it practical for mixing or further processing. Density comes in at roughly 1.6 g/cm³. This translates to a compact profile—a volume that’s easy to measure out whether working with a scale in a pharmaceutical lab or handling commercial shipments.
Solubility data tells us something meaningful about Doxofylline’s utility. It dissolves well in hot water, and displays increased solubility when introduced to solvents like ethanol. This means manufacturers can adjust formulations to fit either fast-release or extended-release pharmaceutical products. Under a microscope, crystals of Doxofylline tend to show well-defined lines, a clue to its purity and the careful conditions maintained during synthesis. Folks working in quality control look for a melting point between 110°C and 115°C. A tight melting range reflects steadiness and points to minimum impurities, which builds trust in product safety down the line.
What makes Doxofylline’s structure stand out is the dioxolane attachment at the seventh position of the xanthine backbone. This adjustment affects both biological and chemical properties. For one, it reduces the risk of stimulant side effects—a common issue with basic methylxanthines—while preserving bronchodilator benefits. Workers should note: the chemical isn’t known for extreme hazard, but handling should always follow standard safety rules for raw chemical powders. Gloves, dust masks, and proper ventilation limit inhalation and skin contact.
Based on Safety Data Sheet (SDS) recommendations, anyone weighing or transferring Doxofylline should avoid direct inhalation of fine dust. Eye protection guards against accidental splashes during lab preparation. Spills clean up easily—most facilities use gentle vacuuming or wet-wiping to prevent airborne particles. In storage, Doxofylline keeps best in airtight containers with no direct sunlight. Temperatures that stay below 25°C prevent breakdown or loss of potency. Even though it’s classified as safe under most guidelines, its chemical nature means no one can ignore the chance of irritation if large amounts of powder escape into the work area.
Global trade relies on precise product identifiers, so Doxofylline moves between borders with the HS Code 2939.39. This code designates its place among heterocyclic compounds with nitrogen atoms. Accurate labeling helps customs authorities and warehousing professionals track everything from pharmaceutical-grade imports to bulk shipments intended for research or formulation. Wherever it ships, the goal stays the same—reduce risk, maintain shelf-life, and protect workers or patients from accidental exposure.
Manufacturers select Doxofylline raw materials based on clear, published specifications: verified molecular weight, tight limits for water content, and certified absence of common contaminants. Labs look not just for density or melting point but assess particle shape and surface area, because these influence how the powder blends or dissolves downstream. Whether delivered in bulk sacks, sealed drums, or small high-purity containers, suppliers certify properties that can be traced right back to original production batches. For buyers, this builds transparency in the supply chain, which fits with modern calls for traceability in every step of pharmaceutical manufacture.
A closer look at hazardous classification tells a story often missed in product catalogs. Doxofylline does not meet severe standards for environmental hazard under ordinary use, though disposal should still follow all local chemical waste rules. Landfill dumping gets a hard ‘no’; instead, leftover stocks get packaged and transferred to licensed disposal contractors. Incineration remains the most common end-of-life route because it breaks down the compound without leaving dangerous residues. Documentation must go hand-in-hand with every step—meeting regulatory needs while keeping neighborhoods and natural resources safe.
Exposure to high concentrations can cause irritation, but incidents remain rare. Occupational health studies posted in recent safety reviews show low evidence for acute toxicity, yet all teams receive annual briefings on chemical hygiene. If problems do occur—say, spills in a busy plant—quick cleanup with proper personal protective gear and trustworthy protocols keeps risks lower than many other industrial chemicals. Having participated in chemical inventory audits, I know how much work goes into labeling barrels, updating MSDS binders, and running emergency drills. In practice, these steps matter more than any single piece of advice about a given powder or raw material.
Chemical producers, researchers, and regulatory officers each bring a different lens to the Doxofylline landscape. Fact-based decisions around storage, handling, and transport reduce risk for everyone. Calls for even tighter identification—potentially with RFID tagging or blockchain ledgers—would make it easier to root out counterfeit material. Improving communication between handlers and users, maybe by updating digital records in real time, helps shrink the gap between laboratory and warehouse. Each link along the chain grows more robust when teams have direct, up-to-date information on properties, hazards, and handling tips that draw on real industry experience, not just datasheet summaries.